Dow Up 0.12% Nasdaq Up 0.53%

XOMA Corporation (XOMA)

-NasdaqGM
4.93 Up 0.34(7.41%) 10:19AM EST - Nasdaq Real Time Price
Prev Close:4.59
Open:4.81
Bid:4.83 x 2400
Ask:4.84 x 4400
1y Target Est:8.86
Beta:4.4
Next Earnings Date:N/A
Day's Range:4.71 - 4.93
52wk Range:3.42 - 9.57
Volume:833,920
Avg Vol (3m):1,383,310
Market Cap:529.44M
P/E (ttm):N/A
EPS (ttm):-1.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
XOMAUp 7.41%529.44M
NVSUp 0.04%229.83B
REGNUp 0.75%41.15B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):18.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.46
Quarterly EPS Est (Dec-14) :-0.13
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.52

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. Its proprietary products comprise gevokizumab, a humanized allosteric-modulating monoclonal antibody that binds to the inflamma... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback